Tenascin-C targeting strategies in cancer
Tenascin C
Matricellular protein
Tenascin
DOI:
10.1016/j.matbio.2024.04.002
Publication Date:
2024-04-18T16:16:23Z
AUTHORS (3)
ABSTRACT
Tenascin-C (TNC) is a matricellular and multimodular glycoprotein highly expressed under pathological conditions, especially in cancer and chronic inflammatory diseases. Since a long time TNC is considered as a promising target for diagnostic and therapeutic approaches in anti-cancer treatments and was already extensively targeted in clinical trials on cancer patients. This review provides an overview of the current most advanced strategies used for TNC detection and anti-TNC theranostic approaches including some advanced clinical strategies. We also discuss novel treatment protocols, where targeting immune modulating functions of TNC could be center stage.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (192)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....